We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
IBA-Radcal

Download Mobile App




Oncology Researchers Find Dual Scanner Effective

By HospiMedica staff writers
Posted on 03 Aug 2001
Researchers in clinical oncology have found that a new dual scanner, combining positron emission tomography (PET) with computed tomography (CT), is a practical and effective approach to acquiring co-registered anatomical and functional images in a single scanning session. More...
The availability of accurately aligned, whole body anatomical and functional images could have a significant impact on diagnosing and staging malignant disease and on identifying and localizing metastases, the authors note. The images
produced by the combined scanner were also used for evaluating response to therapy.

The research paper has received the 1st place award for "Outstanding Basic Science Investigations.” The paper was published in the August 2000 issue of The Journal of Nuclear Medicine, and the award was presented during the Annual Meeting of the Society of Nuclear Medicine in Toronto (Canada.). The authors were from the PET facility and division of nuclear medicine, department of radiology, at the University of Pittsburgh (UPMC, PA, USA;), CTI PET Systems (Knoxville, TN, USA), and Byars Consulting (Oak Ridge, TN, USA).

Criteria used to determine award recipients included presentation of scientific evidence, groundbreaking technology, and contribution to the nuclear medicine field. The dual scanner, called the Smart PET/CT scanner, is the product of Siemens Medical Solutions (Erlangen, Germany). "It is an extreme privilege for our company to have played a part in this important technologic advancement for the earlier and more complete detection, diagnosis, and treatment of a wide variety of cancers,” said Barbara Franciose, president of Siemens Worldwide Nuclear Medicine business.




Related Links:
www.siemensmedical.com

Gold Member
12-Channel ECG
CM1200B
Antipsychotic TDM Assays
Saladax Antipsychotic Assays
Digital Color Doppler Ultrasound System
MS22Plus
Mammo DR Retrofit Solution
DR Retrofit Mammography
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to HospiMedica.com and get access to news and events that shape the world of Hospital Medicine.
  • Free digital version edition of HospiMedica International sent by email on regular basis
  • Free print version of HospiMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of HospiMedica International in digital format
  • Free HospiMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Surgical Techniques

view channel
Image: The AI-based approach identifies lipid regions matched well with histopathology results (Photo courtesy of Hyeong Soo Nam/KAIST)

AI-Based OCT Image Analysis Identifies High-Risk Plaques in Coronary Arteries

Lipid-rich plaques inside coronary arteries are strongly associated with heart attacks and other major cardiac events. While optical coherence tomography (OCT) provides detailed images of vessel structure... Read more

Patient Care

view channel
Image: The revolutionary automatic IV-Line flushing device set for launch in the EU and US in 2026 (Photo courtesy of Droplet IV)

Revolutionary Automatic IV-Line Flushing Device to Enhance Infusion Care

More than 80% of in-hospital patients receive intravenous (IV) therapy. Every dose of IV medicine delivered in a small volume (<250 mL) infusion bag should be followed by subsequent flushing to ensure... Read more

Business

view channel
Image: Medtronic’s intent to acquire CathWorks follows a 2022 strategic partnership with a co-promotion agreement for the FFRangio System (Photo courtesy of CathWorks)

Medtronic to Acquire Coronary Artery Medtech Company CathWorks

Medtronic plc (Galway, Ireland) has announced that it will exercise its option to acquire CathWorks (Kfar Saba, Israel), a privately held medical device company, which aims to transform how coronary artery... Read more
Copyright © 2000-2026 Globetech Media. All rights reserved.